| 000 | 01725 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518084158.0 | ||
| 264 | 0 | _c20201123 | |
| 008 | 202011s 0 0 eng d | ||
| 022 | _a1573-7217 | ||
| 024 | 7 |
_a10.1007/s10549-020-05556-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSarmiento, Samuel | |
| 245 | 0 | 0 |
_aMale breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cApr 2020 |
||
| 300 |
_a471-479 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBreast Neoplasms, Male _xmetabolism |
| 650 | 0 | 4 |
_aCarcinoma, Intraductal, Noninfiltrating _xmetabolism |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDatabases, Factual _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEstrogen Receptor alpha _xmetabolism |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance Carriers _xstatistics & numerical data |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aMcColl, Michael | |
| 700 | 1 | _aMusavi, Leila | |
| 700 | 1 | _aGani, Faiz | |
| 700 | 1 | _aCanner, Joseph K | |
| 700 | 1 | _aJacobs, Lisa | |
| 700 | 1 | _aFu, Fanmeng | |
| 700 | 1 | _aSiotos, Charalampos | |
| 700 | 1 | _aHabibi, Mehran | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 180 _gno. 2 _gp. 471-479 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-020-05556-y _zAvailable from publisher's website |
| 999 |
_c30617509 _d30617509 |
||